摘要
对近五年中医药治疗肝纤维化(liver fibrosis,HF)的疗效及动物实验研究进行综述,指出HF是一种受多种因素影响的肝损伤愈合反应,是各种慢性肝病的共同病理基础,目前现代医药尚无特效方法与药物,仍需寻找更为有效的终止HF进展甚或逆转至正常、减轻患者痛苦和提高患者生活质量的治疗方法;近年来大量临床数据证实扶正化瘀片、安络化纤丸、鳖甲煎丸、复方鳖甲软肝片等抗HF疗效显著。
By conducting an overviewing of clinical effects of TCM therapy of hepatic fibrosis(HF)and animal experimental research,HF is a kind of liver injury healing response influenced by many factors,as a common pathological basis of all kinds of chronic liver diseases,there was no specific method and drugs in modern medicine,we still need to find more effective therapies in order to stop the progression of HF or even reverse to normal,reduce the patients'pain and improve the patients'quality of life;in the recent years,large amounts of clinical data has proved that Fuzheng Huayu tablets,Anluo Huaqian pills,Biejiajian pills and compound Biejia Ruangan tables present noticeable clinical effects in the treatment of HF.
作者
李瑛
胡振斌
张旭
徐昆
陈彩凤
LI Ying;HU Zhenbin;ZHANG Xu;XU Kun;CHEN Caifeng(Guangxi University of Chinese Medicine,Nanning 530000,China;The First Affiliated Hospital of Guangxi University of Chinese Medicine,Nanning 530000,China)
出处
《西部中医药》
2023年第7期138-141,共4页
Western Journal of Traditional Chinese Medicine
基金
国家科技重大专项课题子课题(2018ZX107255050002)。
